Profil
Ian Ivory was Chairman of Finsbury Worldwide Pharmaceutical Trust Plc until July 23, 2008.
He was a Member of Lloyd from 1978 to 1996 and served as a Director of Premium Underwriting Plc.
Mr. Ivory is a Chartered Accountant.
Ehemalige bekannte Positionen von Ian Ivory
| Unternehmen | Position | Ende |
|---|---|---|
Finsbury Worldwide Pharmaceutical Trust Plc
 Finsbury Worldwide Pharmaceutical Trust Plc Investment Trusts/Mutual FundsMiscellaneous Finsbury Worldwide Pharmaceutical Trust Plc provides investment on pharmaceutical and biotechnology sector on a global scale. It reduces risk through extensive fundamental research, worldwide exposure, position limits and balanced market capitalisations. The company was founded in 1995 and is headquartered in London, the United Kingdom. | Vorsitzender | 23.07.2008 |
Hardy Underwriting Group Ltd
 Hardy Underwriting Group Ltd MiscellaneousMiscellaneous Hardy Underwriting Group is a management and holding company for the Hardy group of companies.The Group’s principal activities are acting as managing agent of syndicate 382 at Lloyd’s and underwriting on syndicate 382 through a limited liability corporate member. | Direktor/Vorstandsmitglied | 08.02.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Hardy Underwriting Group Ltd
Hardy Underwriting Group Ltd MiscellaneousMiscellaneous Hardy Underwriting Group is a management and holding company for the Hardy group of companies.The Group’s principal activities are acting as managing agent of syndicate 382 at Lloyd’s and underwriting on syndicate 382 through a limited liability corporate member. | Miscellaneous |
Finsbury Worldwide Pharmaceutical Trust Plc
Finsbury Worldwide Pharmaceutical Trust Plc Investment Trusts/Mutual FundsMiscellaneous Finsbury Worldwide Pharmaceutical Trust Plc provides investment on pharmaceutical and biotechnology sector on a global scale. It reduces risk through extensive fundamental research, worldwide exposure, position limits and balanced market capitalisations. The company was founded in 1995 and is headquartered in London, the United Kingdom. | Miscellaneous |
